report-image

Cisplatin Market Analysis Application (Oncology, Non-Oncology), Type of Cancer (Lung cancer, Ovarian cancer, Testicular cancer, Others), End-User (Hospitals, Cancer Treatment Centers, Research Institutes), Distribution Channel (Pharmaceutical wholesalers, Direct sales to hospitals, Online pharmacies) and by Region: Global Forecast, 2024 - 2034.

  • PUBLISHED ON
  • 2024-04-19
  • NO OF PAGES
  • 231
  • CATEGORY
  • Healthcare & Life Sciences

Market Overview

The Cisplatin market is predicted to develop at a compound annual growth rate (CAGR) of XX% from 2024 to 2034, when it is projected to reach USD XX Million, based on an average growth pattern. The market is estimated to reach a value of USD XX Million in 2024.

 

SOURCE: We Market Research

Cisplatin is a chemotherapy medication used to treat a variety of cancers, including testicular, ovarian, bladder, lung, cervical, and head and neck cancer. When administered intravenously in therapeutic settings, it inhibits cancer cell proliferation, resulting in their death. Despite its effectiveness, cisplatin can cause nausea, vomiting, kidney impairment, hearing loss, and nerve damage because it affects healthy cells. As a result, its use necessitates close monitoring by healthcare specialists to manage these side effects. Cisplatin is frequently used with other chemotherapeutic medicines to improve cancer patients' treatment outcomes, highlighting the necessity of customized cancer care.

A popular chemotherapy medication, cisplatin is in high demand for a variety of reasons. Increased cancer incidence rates, particularly in older populations, are the driving force behind its usage, which is also made possible by improvements in cancer therapy and early detection programs. Favorable reimbursement and regulatory frameworks promote its use, and advancements in technology enhance its efficacy and safety. Expanded healthcare infrastructures, particularly in developing countries, enable more access to cisplatin-based treatments. Collaborations and partnerships in the healthcare sector expedite research and development and result in novel product formulations and applications. These factors contribute to the expansion and significance of cisplatin in cancer therapy and highlight the critical role that it plays in patient care.

 

Market Scope

Report Attributes

Description

Market Size in 2024

USD XX Million

Market Forecast in 2034

USD XX Million

CAGR % 2024-2034

XX%

Base Year

2023

Historic Data

2016-2022

Forecast Period

2024-2034

Report USP

 

Production, Consumption, company share, company heatmap, company production capacity, growth factors and more

Segments Covered

by Application, by Type of Cancer, by End-User, by Distribution Channel and By Region

Regional Scope

North America, Europe, APAC, South America and Middle East and Africa

Country Scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria

 

Cisplatin Industry: Dynamics & Restrains


 Market opportunity:


 

We Market Research: Cisplatin Dashboard

Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.


Cisplatin Segmentation

Market- By Application Analysis

By Application, the Cisplatin Market is Categories into Oncology, Non-Oncology. The Oncology segment accounts for the largest share of around 68% in 2024.


Cisplatin is a key component of oncology treatment plans for a number of cancers, including lung, ovarian, testicular, and bladder tumors. Demand is driven by its effectiveness in stopping DNA replication in cancer cells, particularly in combination medicines that improve the prognosis of cancer treatment.

The following segments are part of an in-depth analysis of the global Cisplatin market:

Market Segments

 

By  Type of Cancer

·         Lung cancer

·         Ovarian cancer

·         Testicular cancer

·         Others

By  End-User

·         Hospitals

·         Cancer Treatment Centers

·         Research Institutes

By  Distribution Channel

·         Pharmaceutical wholesalers

·         Direct sales to hospitals

·         Online pharmacies

  

Cisplatin Industry: Regional Analysis

Asia Pacific Market Forecast

Asia Pacific dominate the Cisplatin Market with the highest revenue generating market with share of more than 47%. The market for cisplatin in Asia Pacific is dominated due to a number of factors, including an aging population, a growing middle class, rising cancer awareness, better access to healthcare, and rising investments in healthcare infrastructure.


North America Market Statistics

North America is second largest market for Cisplatin due to Presence of established pharmaceutical companies, high prevalence of cancer, advanced healthcare infrastructure, and strong R&D investments drive demand for cisplatin in cancer treatment.

Europe Market Forecasts

Europe is expected to be the fastest-growing regional segment of the Cisplatin market during the forecast period. In the Europe, increasing cancer incidence, supportive regulatory environment, growing adoption of novel therapies incorporating cisplatin, and emphasis on personalized medicine contribute to market growth.

Key Market Players 

The Cisplatin Market is dominated by a few large companies, such as

·         Pfizer

·         Eli Lilly and Company

·         David Bull Laboratories

·         Hospira

·         Bedford Pharmaceuticals

·         West-Ward Pharmaceuticals

·         Athenex Pharmaceutical

·         WG Critical Care

·         Alvogen

·         Gland Pharma (Fosun Pharma)

·         Yunnan Biological Valley Pharmaceutical

·         Jiangsu Haosen Pharmaceutica

·         Other
                                                

 


1.      Global Cisplatin Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Cisplatin Market Scope and Market Estimation

1.2.1. Global Cisplatin Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)

1.2.2. Global Cisplatin Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034

1.3.    Market Segmentation

1.3.1. Component of Global Cisplatin Market

1.3.2. Technology of Global Cisplatin Market

1.3.3. End-user of Global Cisplatin Market

1.3.4. Region of Global Cisplatin Market

2.      Executive Summary

2.1.    Global Cisplatin Market Industry Trends under COVID-19 Outbreak

2.1.1. Global COVID-19 Status Overview

2.1.2. Influence of COVID-19 Outbreak on Global Cisplatin Market Industry Development

2.2.    Market Dynamics

2.2.1. Drivers

2.2.2. Limitations

2.2.3. Opportunities

2.2.4. Impact Analysis of Drivers and Restraints

2.3.    Pricing Trends Analysis & Average Selling Prices (ASPs)

2.4.    Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.5.    Porter’s Five Forces Analysis

2.5.1. Bargaining Power of Suppliers

2.5.2. Bargaining Power of Buyers

2.5.3. Threat of Substitutes

2.5.4. Threat of New Entrants

2.5.5. Competitive Rivalry

2.6.    Value Chain / Ecosystem Analysis

2.7.    Russia-Ukraine War Impacts Analysis

2.8.    Economic Downturn Analysis

2.9.      Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Cisplatin Market Estimates & Historical Trend Analysis (2019 - 2023)

4.      Global Cisplatin Market Estimates & Forecast Trend Analysis, by TYPE OF CANCER

4.1.    Global Cisplatin Market Revenue (US$ Mn) Estimates and Forecasts, by TYPE OF CANCER, 2019 to 2034

4.1.1. Lung cancer

4.1.2. Ovarian cancer

4.1.3. Testicular cancer

4.1.4. Others

5.      Global Cisplatin Market Estimates & Forecast Trend Analysis, by Application

5.1.    Global Cisplatin Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2019 to 2034

5.1.1. Oncology

5.1.2. Non-Oncology

6.      Global Cisplatin Market Estimates & Forecast Trend Analysis, by End-user

6.1.    Global Cisplatin Market Revenue (US$ Mn) Estimates and Forecasts, by End-user, 2019 to 2034

6.1.1. Hospitals

6.1.2. Cancer Treatment Centers

6.1.3. Research Institutes

7.      Global Cisplatin Market Estimates & Forecast Trend Analysis, by DISTRIBUTION CHANNEL

7.1.    Global Cisplatin Market Revenue (US$ Mn) Estimates and Forecasts, by End-user, 2019 to 2034

7.1.1. Pharmaceutical wholesalers

7.1.2. Direct sales to hospitals

7.1.3. Online pharmacies

8.      Global Cisplatin Market Estimates & Forecast Trend Analysis, by Region

8.1.    Global Cisplatin Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034

8.1.1. North America

8.1.2. Europe

8.1.3. Asia Pacific

8.1.4. Middle East & Africa

8.1.5. South America

9.      North America Cisplatin Market: Estimates & Forecast Trend Analysis

9.1.    North America Cisplatin Market Assessments & Key Findings

9.1.1. North America Cisplatin Market Introduction

9.1.2. North America Cisplatin Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

9.1.2.1.   By TYPE OF CANCER

9.1.2.2.   By Application

9.1.2.3.   By End-user

9.1.2.4.   By DISTRIBUTION CHANNEL

9.1.2.5.   By Country

9.1.2.5.1.     The U.S.

9.1.2.5.2.     Canada

9.1.2.5.3.     Mexico

10.  Europe Cisplatin Market: Estimates & Forecast Trend Analysis

10.1.  Europe Cisplatin Market Assessments & Key Findings

10.1.1.   Europe Cisplatin Market Introduction

10.1.2.   Europe Cisplatin Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

10.1.2.1.    By TYPE OF CANCER

10.1.2.2.    By Application

10.1.2.3.    By End-user

10.1.2.4.    By DISTRIBUTION CHANNEL

10.1.2.5.    By Country

10.1.2.5.1. Germany

10.1.2.5.2. U.K.

10.1.2.5.3. France

10.1.2.5.4. Italy

10.1.2.5.5. Spain

10.1.2.5.6. Russia

10.1.2.5.7. Rest of Europe

11.  Asia Pacific Cisplatin Market: Estimates & Forecast Trend Analysis

11.1.  Asia Pacific Market Assessments & Key Findings

11.1.1.   Asia Pacific Cisplatin Market Introduction

11.1.2.   Asia Pacific Cisplatin Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

11.1.2.1.    By TYPE OF CANCER

11.1.2.2.    By Application

11.1.2.3.    By End-user

11.1.2.4.    By DISTRIBUTION CHANNEL

11.1.2.5.    By Country

11.1.2.5.1. China

11.1.2.5.2. Japan

11.1.2.5.3. India

11.1.2.5.4. Australia

11.1.2.5.5. South Korea

11.1.2.5.6. ASEAN

11.1.2.5.7. Rest of Asia Pacific

12.  Middle East & Africa Cisplatin Market: Estimates & Forecast Trend Analysis

12.1.  Middle East & Africa Market Assessments & Key Findings

12.1.1.   Middle East & Africa Cisplatin Market Introduction

12.1.2.   Middle East & Africa Cisplatin Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

12.1.2.1.    By TYPE OF CANCER

12.1.2.2.    By Application

12.1.2.3.    By End-user

12.1.2.4.    By DISTRIBUTION CHANNEL

12.1.2.5.    By Country

12.1.2.5.1. U.A.E.

12.1.2.5.2. Saudi Arabia

12.1.2.5.3. Egypt

12.1.2.5.4. South Africa

12.1.2.5.5. Rest of Middle East & Africa

13.  South America Cisplatin Market: Estimates & Forecast Trend Analysis

13.1.  South America Market Assessments & Key Findings

13.1.1.   South America Cisplatin Market Introduction

13.1.2.   South America Cisplatin Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

13.1.2.1.    By TYPE OF CANCER

13.1.2.2.    By Application

13.1.2.3.    By End-user

13.1.2.4.    By DISTRIBUTION CHANNEL

13.1.2.5.    By Country

13.1.2.5.1. Brazil

13.1.2.5.2. Argentina

13.1.2.5.3. Colombia

13.1.2.5.4. Rest of South America

14.  Competition Landscape

14.1.  Global Cisplatin Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

14.2.  Global Cisplatin Market Competition White Space Analysis, By End-user

14.3.  Global Cisplatin Market Competition Heat Map Analysis, By End-user

14.4.  Global Cisplatin Market Concentration & Company Market Shares (%) Analysis, 2022

15.  Company Profiles

15.1.                     Pfizer

15.1.1.   Company Overview & Key Stats

15.1.2.   Financial Performance & KPIs

15.1.3.   Product Portfolio

15.1.4.   Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

15.2.      Eli Lilly and Company

15.3.      David Bull Laboratories

15.4.      Hospira

15.5.      Bedford Pharmaceuticals

15.6.      West-Ward Pharmaceuticals

15.7.      Athenex Pharmaceutical

15.8.      WG Critical Care

15.9.      Alvogen

15.10.  Gland Pharma (Fosun Pharma)

15.11.  Yunnan Biological Valley Pharmaceutical

15.12.  Jiangsu Haosen Pharmaceutica

15.13.  Other

16.  Research Methodology

16.1.  External Transportations / Databases

16.2.  Internal Proprietary Database

16.3.  Primary Research

16.4.  Secondary Research

16.5.  Assumptions

16.6.  Limitations

16.7.  Report FAQs

17.  Research Findings & Conclusion

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process




We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).

Solution

The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.


Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


Conclusion

The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.

Frequently Asked Questions

What is the market size of Cisplatin Market in 2024?

Cisplatin Market was valued at USD XX Million in 2024.

What is the growth rate for the Cisplatin Market?

Cisplatin Market size will increase at approximate CAGR of XX% during the forecasted period.

Which are the top companies operating within the market?

Major companies operating within the Cisplatin Market Are Pfizer, Eli Lilly and Company, David Bull Laboratories, Hospira, Bedford Pharmaceuticals, West-Ward Pharmaceuticals, Athenex Pharmaceutical, WG Critical Care, Alvogen, Gland Pharma (Fosun Pharma), Yunnan Biological Valley Pharmaceutical, Jiangsu Haosen Pharmaceutica and Other.

Which region dominates the Cisplatin Market?

Asia Pacific dominates the market with an active share of 47%.

Sample Request Customized Requirement Speak to Analyst Check Discount
CHOOSE LICENSE TYPE
QLOUD
Pricing

Select a license type that suits your business needs

Single User Access

US $3750

Only Three Thousand Seven Hundred Fifty US dollar

Buy Now
  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4750

Only Four Thousand Seven Hundred Fifty US dollar

Buy Now
  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5750

Only Five Thousand Seven Hundred Fifty US dollar

Buy Now
  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI